Advertisement
Screener

Perrigo Company plc (PRGO) Increase (Decrease) in Other Operating Assets and Liabilities, Net

2.8 / 5 stars · 68/120 Roast Me

Perrigo Company plc Increase (Decrease) in Other Operating Assets and Liabilities, Net

Perrigo Company plc (PRGO) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-02-26

  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-27 was $0.00.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-28 was $2.50M, a 91.86% decline year-over-year.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-03-29 was -$2.50M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $0.00.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$1.50M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$25.90M.
  • Perrigo Company plc increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$35.20M, a 848.94% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filedIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 monthIncrease (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$2.50M
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2025-09-27$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$2.50M
derived: sum of 2 quarters · filed 2025-11-05
$0.00
10-Q · filed 2025-11-05
$19.60M
derived: sum of 4 quarters · filed 2026-02-26
2025-06-28$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$0.00
10-Q · filed 2025-08-06
$19.60M
derived: sum of 3 quarters · filed 2026-02-26
-$14.80M
derived: sum of 4 quarters · filed 2026-02-26
2025-03-29-$2.50M
10-Q · filed 2025-05-07
$17.10M
derived: sum of 2 quarters · filed 2026-02-26
-$17.30M
derived: sum of 3 quarters · filed 2026-02-26
$13.40M
derived: sum of 4 quarters · filed 2026-02-26
2024-12-31$19.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$14.80M
derived: sum of 2 quarters · filed 2026-02-26
$15.90M
derived: sum of 3 quarters · filed 2026-02-26
-$1.50M
10-K · filed 2026-02-26
2024-09-28-$34.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$3.70M
derived: sum of 2 quarters · filed 2025-11-05
-$21.10M
10-Q · filed 2025-11-05
-$36.00M
10-Q · filed 2024-11-06
-$28.20M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-29$30.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$13.30M
10-Q · filed 2025-08-06
$6.20M
derived: sum of 3 quarters · filed 2026-02-26
$3.20M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-30-$17.40M
10-Q · filed 2025-05-07
-$24.50M
derived: sum of 2 quarters · filed 2026-02-26
-$27.50M
derived: sum of 3 quarters · filed 2026-02-26
-$33.10M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$10.10M
derived: sum of 2 quarters · filed 2026-02-26
-$15.70M
derived: sum of 3 quarters · filed 2026-02-26
-$25.90M
10-K · filed 2026-02-26
-$33.50M
10-K · filed 2024-02-27
2023-09-30-$3.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$8.60M
derived: sum of 2 quarters · filed 2024-11-06
-$18.80M
10-Q · filed 2024-11-06
-$31.60M
derived: sum of 4 quarters · filed 2025-02-28
2023-07-01-$5.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
-$15.80M
10-Q · filed 2024-08-02
-$28.60M
derived: sum of 3 quarters · filed 2025-02-28
-$42.30M
derived: sum of 4 quarters · filed 2025-02-28
2023-04-01-$10.20M
10-Q · filed 2024-05-07
-$23.00M
derived: sum of 2 quarters · filed 2025-02-28
-$36.70M
derived: sum of 3 quarters · filed 2025-02-28
-$45.30M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$12.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$26.50M
derived: sum of 2 quarters · filed 2025-02-28
-$35.10M
derived: sum of 3 quarters · filed 2025-02-28
-$35.20M
10-K · filed 2025-02-28
2022-10-01-$13.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$22.30M
derived: sum of 2 quarters · filed 2023-11-07
-$22.40M
10-Q · filed 2023-11-07
-$54.50M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02-$8.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$8.70M
10-Q · filed 2023-08-08
-$21.40M
10-Q · filed 2022-08-09
-$40.80M
derived: sum of 3 quarters · filed 2024-02-27
$27.20M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02-$100.00K
10-Q · filed 2023-05-09
-$8.30M
10-Q · filed 2022-05-11
-$32.20M
derived: sum of 2 quarters · filed 2024-02-27
$35.80M
derived: sum of 3 quarters · filed 2024-02-27
$27.10M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31-$32.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$35.90M
derived: sum of 2 quarters · filed 2024-02-27
$27.20M
derived: sum of 3 quarters · filed 2024-02-27
$4.70M
10-K · filed 2024-02-27
2021-10-02$68.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$59.30M
derived: sum of 2 quarters · filed 2022-11-08
$36.80M
10-Q · filed 2022-11-08
$40.60M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03-$8.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$31.20M
10-Q · filed 2022-08-09
-$27.40M
derived: sum of 3 quarters · filed 2023-02-28
-$39.10M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03-$22.50M
10-Q · filed 2022-05-11
-$18.70M
derived: sum of 2 quarters · filed 2023-02-28
-$30.40M
derived: sum of 3 quarters · filed 2023-02-28
-$39.10M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$3.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$7.90M
derived: sum of 2 quarters · filed 2023-02-28
-$16.60M
derived: sum of 3 quarters · filed 2023-02-28
-$10.10M
10-K · filed 2023-02-28
$2.20M
10-K · filed 2021-03-01
2020-09-26-$11.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$20.40M
derived: sum of 2 quarters · filed 2021-11-12
-$13.90M
10-Q · filed 2021-11-12
-$20.50M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27-$8.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$2.20M
10-Q · filed 2021-08-11
-$8.80M
derived: sum of 3 quarters · filed 2022-03-01
-$11.90M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$6.50M
10-Q · filed 2021-05-12
-$100.00K
derived: sum of 2 quarters · filed 2022-03-01
-$3.20M
derived: sum of 3 quarters · filed 2022-03-01
-$7.80M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$9.70M
derived: sum of 2 quarters · filed 2022-03-01
-$14.30M
derived: sum of 3 quarters · filed 2022-03-01
-$27.20M
10-K · filed 2022-03-01
2019-09-28-$3.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$7.70M
derived: sum of 2 quarters · filed 2020-11-05
-$20.60M
10-Q · filed 2020-11-05
-$15.90M
10-Q · filed 2019-11-06
-$16.20M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29-$4.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$17.50M
10-Q · filed 2020-08-05
-$19.90M
10-Q · filed 2019-08-08
-$13.10M
derived: sum of 3 quarters · filed 2021-03-01
-$14.60M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30-$12.90M
10-Q · filed 2020-05-05
-$9.20M
10-Q · filed 2019-05-09
-$8.50M
derived: sum of 2 quarters · filed 2021-03-01
-$10.00M
derived: sum of 3 quarters · filed 2021-03-01
-$26.30M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$4.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$2.90M
derived: sum of 2 quarters · filed 2021-03-01
-$13.40M
derived: sum of 3 quarters · filed 2021-03-01
$8.80M
10-K · filed 2021-03-01
2018-09-29-$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$17.80M
derived: sum of 2 quarters · filed 2019-11-06
$4.40M
10-Q · filed 2019-11-06
$12.70M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30-$16.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$5.90M
10-Q · filed 2019-08-08
$14.20M
derived: sum of 3 quarters · filed 2020-02-27
-$2.60M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$22.20M
10-Q · filed 2019-05-09
$30.50M
derived: sum of 2 quarters · filed 2020-02-27
$13.70M
derived: sum of 3 quarters · filed 2020-02-27
$100.00K
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$8.50M
derived: sum of 2 quarters · filed 2020-02-27
-$22.10M
derived: sum of 3 quarters · filed 2020-02-27
$4.80M
10-K · filed 2020-02-27
2017-09-30-$16.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$30.40M
derived: sum of 2 quarters · filed 2018-11-08
-$3.50M
10-Q · filed 2018-11-08
-$600.00K
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01-$13.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$13.30M
10-Q · filed 2018-08-09
$16.20M
derived: sum of 3 quarters · filed 2019-02-27
-$3.80M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01$26.90M
10-Q · filed 2018-05-08
$29.80M
derived: sum of 2 quarters · filed 2019-02-27
$9.80M
derived: sum of 3 quarters · filed 2019-02-27
$38.40M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$17.10M
derived: sum of 2 quarters · filed 2019-02-27
$11.50M
derived: sum of 3 quarters · filed 2019-02-27
$12.30M
10-K · filed 2019-02-27
2016-10-01-$20.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$8.60M
derived: sum of 2 quarters · filed 2017-11-09
$9.40M
10-Q · filed 2017-11-09
$31.00M
10-Q · filed 2016-11-10
$300.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02$28.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$29.40M
10-Q · filed 2017-08-10
$45.40M
10-Q · filed 2016-08-10
$20.30M
derived: sum of 3 quarters · filed 2018-03-01
$26.50M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02$800.00K
10-Q · filed 2017-05-30
$25.30M
10-Q · filed 2016-05-16
-$8.30M
derived: sum of 2 quarters · filed 2018-03-01
-$2.10M
derived: sum of 3 quarters · filed 2018-03-01
-$24.60M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$9.10M
derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01
-$2.90M
10-K · filed 2018-03-01
$4.80M
10-KT · filed 2016-02-25
-$25.40M
derived: sum of 3 quarters · filed 2018-03-01
-$21.60M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26$6.20M
10-Q · filed 2015-11-02
-$16.30M
derived: sum of 2 quarters · filed 2017-05-22
-$13.70M
10-Q/A · filed 2017-05-23
$6.70M
10-Q · filed 2016-11-10
-$8.10M
derived: sum of 4 quarters · filed 2017-05-22
2015-06-27-$22.50M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22
-$18.70M
10-Q/A · filed 2017-05-22
$600.00K
10-Q · filed 2016-08-10
-$14.30M
derived: sum of 3 quarters · filed 2017-05-22
-$600.00K
10-K · filed 2018-03-01
$16.80M
10-K · filed 2015-08-13
2015-03-28$3.80M
10-Q/A · filed 2017-05-22
$2.00M
10-Q · filed 2016-05-16
$8.20M
derived: sum of 2 quarters · filed 2017-05-22
$18.40M
10-Q · filed 2015-04-29
-$15.10M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27$4.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05
$16.40M
10-Q · filed 2015-02-05
-$18.90M
derived: sum of 3 quarters · filed 2017-05-22
-$31.30M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27$12.00M
10-Q · filed 2015-11-02
-$23.30M
derived: sum of 2 quarters · filed 2017-05-22
-$35.70M
derived: sum of 3 quarters · filed 2017-05-22
-$17.50M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28-$35.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
-$47.70M
derived: sum of 2 quarters · filed 2017-05-22
-$29.50M
derived: sum of 3 quarters · filed 2017-05-22
-$31.90M
10-K · filed 2017-05-22
-$33.90M
10-K · filed 2014-08-14
2014-03-29-$12.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29
$5.80M
derived: sum of 2 quarters · filed 2015-04-29
$3.40M
10-Q · filed 2015-04-29
$6.70M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-28$18.20M
derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05
$15.80M
10-Q · filed 2015-02-05
$19.10M
derived: sum of 3 quarters · filed 2016-02-25
$4.40M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-28-$2.40M
8-K · filed 2014-11-20
$900.00K
derived: sum of 2 quarters · filed 2016-02-25
-$13.80M
derived: sum of 3 quarters · filed 2016-02-25
2013-06-29$3.30M
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25
-$11.40M
derived: sum of 2 quarters · filed 2016-02-25
-$15.30M
10-KT · filed 2016-02-25
2013-03-30-$14.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07
-$18.60M
10-Q · filed 2014-05-07
2012-12-29-$3.90M
10-Q · filed 2014-02-06
2012-06-30$5.70M
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38